The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.

Jake Orlick, an 11-year-old boy, is fighting a courageous battle against Ewing Sarcoma, a rare form of bone cancer. Our Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, may be on the verge of a breakthrough with a novel new experimental treatment for relapsed Ewing sarcoma.

Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, is set to launch a novel, experimental approach to treating relapsed Ewing sarcoma, as highlighted in this story in the Philadelphia Inquirer.

Children’s Hospital of Philadelphia views diversity as a key driver of achievement, particularly when innovation is critical.

CHOP’s Food Allergy Center was one of the research sites that helped test and develop the new drug.

The Cardiac Center at Children’s Hospital of Philadelphia (CHOP) participated in the annual Pediatric Cardiac Intensive Care Society (PCICS) Conference.

Caregiver burnout is not only normal, but inevitable. A CHOP psychologist offers advice for struggling families.

Poor sleep habits and sleep disorders are very common in early childhood, especially in children exposed to multiple family and environmental risks like parental depression and poverty, say researchers from Children’s Hospital of Philadelphia (CHOP) in a study recently published in the journal Sleep.

2019 was a year of great strides for the Wyss/Campbell Center for Thoracic Insufficiency. Read about new research projects and efforts to improve outcomes for children with chest wall/pulmonary and spinal deformities.

The first-of-its-kind treatment can reduce a child's allergic reaction to peanuts.